Javelin Pharms Inc Drug Patent Portfolio
Javelin Pharms Inc owns 1 orange book drug protected by 2 US patents Given below is the list of Javelin Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8946292 | Formulations of low dose diclofenac and beta-cyclodextrin | 22 Mar, 2027 | Active |
| US6407079 | Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation | 18 Jun, 2019 | Expired |
Latest Legal Activities on Javelin Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Javelin Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Jul, 2022 | US8946292 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Jul, 2018 | US8946292 |
|
Recordation of Patent Grant Mailed
Critical
| 03 Feb, 2015 | US8946292 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Feb, 2015 | US8946292 |
|
Email Notification
Critical
| 15 Jan, 2015 | US8946292 |
|
Issue Notification Mailed
Critical
| 14 Jan, 2015 | US8946292 |
| Dispatch to FDC | 31 Dec, 2014 | US8946292 |
|
Application Is Considered Ready for Issue
Critical
| 30 Dec, 2014 | US8946292 |
|
Issue Fee Payment Verified
Critical
| 17 Dec, 2014 | US8946292 |
|
Issue Fee Payment Received
Critical
| 17 Dec, 2014 | US8946292 |
|
Electronic Review
Critical
| 21 Oct, 2014 | US8946292 |
|
Email Notification
Critical
| 21 Oct, 2014 | US8946292 |
|
Mail Notice of Allowance
Critical
| 21 Oct, 2014 | US8946292 |
|
Notice of Allowance Data Verification Completed
Critical
| 07 Oct, 2014 | US8946292 |
|
Case Docketed to Examiner in GAU
Critical
| 07 Oct, 2014 | US8946292 |
Javelin Pharms Inc's Drug Patent Litigations
Javelin Pharms Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 05, 2000, against patent number US6407079. The petitioner , challenged the validity of this patent, with PITHA V. MULLER as the respondent. Click below to track the latest information on how companies are challenging Javelin Pharms Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6407079 | October, 2000 |
Decision
(05 Oct, 2000)
| PITHA V. MULLER | |
Javelin Pharms Inc's Family Patents
Javelin Pharms Inc Drug List
Given below is the complete list of Javelin Pharms Inc's drugs and the patents protecting them.
1. Dyloject
Dyloject is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8946292 | Formulations of low dose diclofenac and beta-cyclodextrin |
22 Mar, 2027
(2 years from now)
| Active |
| US6407079 | Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation |
18 Jun, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dyloject's drug page